Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Common Equity (2016 - 2025)

United Health Products (UEEC) has disclosed Common Equity for 15 consecutive years, with -$3.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 58.18% to -$3.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.3 million, a 58.18% decrease, with the full-year FY2024 number at -$2.4 million, down 42.56% from a year prior.
  • Common Equity was -$3.3 million for Q3 2025 at United Health Products, down from -$3.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $41273.0 in Q1 2021 to a low of -$3.3 million in Q3 2025.
  • A 5-year average of -$1.9 million and a median of -$2.0 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 106.32% in 2021, then plummeted 4981.31% in 2022.
  • United Health Products' Common Equity stood at -$1.1 million in 2021, then crashed by 80.83% to -$2.1 million in 2022, then rose by 16.98% to -$1.7 million in 2023, then crashed by 42.56% to -$2.4 million in 2024, then crashed by 36.65% to -$3.3 million in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Common Equity are -$3.3 million (Q3 2025), -$3.2 million (Q2 2025), and -$2.9 million (Q1 2025).